KATELYN GOODWIN: Open Payments
NPI 1821647215 · DAWSONVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 21 payments from 13 companies in 2025. Trend: 2023 $645 · 2024 $384 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $94 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Amgen Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Corcept Therapeutics | 1 | $26 |
| Corium, LLC | 1 | $25 |
| Dexcom, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| SANOFI PASTEUR INC. | 1 | $19 |
Products named: JARDIANCE, Auvelity, TZIELD, Rybelsus, OTEZLA, Ozempic, Korlym, Azstarys.
Industry payments across GA — which companies pay providers there.
